HKEX: 7666
2026 Interim Report
Earlier from Metis Techbio Co., Ltd. Class H
- METiS TechBio and Boulevard Bio Enter Global License Agreement for Trispecific T-cell Engager
- METiS TechBio to Present Late-Breaking Data on Near-Complete Cardiomyocyte Delivery at CRS 2026